EGFR and non-small cell lung carcinoma: Hirsch et al. reported EGFR overexpression in squamous cell and ADC subtype of NSCLCs at the level of 62% [49], whereas the National Comprehensive Cancer Network stated that over 80% of NSCLC patients have detectable levels of EGFR in tumors.